Watch this video to learn more!
Entrepreneurs in Clinical Academia (ECA) is an exciting initiative from the Federation of Clinical Immunology Societies (FOCIS) offering medical academics in Europe the chance to discover more about the drug development process and how to get the most out of research. It is supported by Celgene and delivered by INSEAD, a pioneer of international business education.
ECA is a once-in-a-lifetime chance to discover the business potential of research breakthroughs, and is open to clinical and academic researchers currently involved in an immunology or inflammatory research programme in Europe, and interested in gaining the awareness required to progress innovative molecules to market. Throughout the week, successful candidates will be working in groups to apply their learnings to build a business plan presentation relating to a specific case study drug.
The course is interactive, intensive, and a unique way to learn the language of business from a scientist perspective!
Applications for the 2017 course are now open. A list of successful candidates will be posted to the site, closer to the course dates.
Successful candidates are chosen by an independent Candidate Selection Board from FOCIS and INSEAD. Applicants are ranked based on their:
- Research performance
- Entrepreneurial motivation and performance, as seen in their CV
- Answers to questions in the application form
- Strength of their referee recommendation
The top 20 candidates are accepted or, if two candidates ranked after candidate 19 have the same score, 21 candidates are accepted.
16–20 October 2017; INSEAD, Fontainebleau, France